Zongxin Q. Ling

79 Qingchun Rd
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Gut dysbiosis and systemic inflammation in elderly hypertensive patients with amnestic mild cognitive impairment.

Gut dysbiosis and systemic inflammation in elderly hypertensive patients with amnestic mild cognitive impairment.

Journal: Frontiers in immunology

Published: May 03, 2026

Microbial SCFAs as epigenetic mediators: fine-tuning the gut-brain axis in neurodegenerative disorders.

Microbial SCFAs as epigenetic mediators: fine-tuning the gut-brain axis in neurodegenerative disorders.

Journal: Current research in microbial sciences

Published: March 09, 2026

Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease.

Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease.

Journal: Free radical biology & medicine

Published: February 25, 2026

Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patients.

Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patients.

Journal: Human vaccines & immunotherapeutics

Published: December 03, 2025

Impact of carbapenem-resistant Klebsiella pneumoniae infection on gut microbiota and host immunity: a case-control study.

Impact of carbapenem-resistant Klebsiella pneumoniae infection on gut microbiota and host immunity: a case-control study.

Journal: Microbiology spectrum

Published: November 20, 2025

Power and sample-size estimation in human microbiome research.

Power and sample-size estimation in human microbiome research.

Journal: Med (New York, N.Y.)

Published: September 17, 2025

Gut microbiota dysbiosis and systemic inflammation in elderly Chinese hypertensive patients: a case-control study.

Gut microbiota dysbiosis and systemic inflammation in elderly Chinese hypertensive patients: a case-control study.

Journal: Frontiers in immunology

Published: July 09, 2025

Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome.

Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome.

Journal: Frontiers in immunology

Published: June 27, 2025

The microbiota-gut-brain axis in depression: unraveling the relationships and therapeutic opportunities.

The microbiota-gut-brain axis in depression: unraveling the relationships and therapeutic opportunities.

Journal: Frontiers in immunology

Published: June 10, 2025

Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection.

Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection.

Journal: Journal of translational medicine

Published: June 02, 2025

Schizophrenia-associated alterations in fecal mycobiota and systemic immune dysfunction: a cohort study of elderly Chinese patients.

Schizophrenia-associated alterations in fecal mycobiota and systemic immune dysfunction: a cohort study of elderly Chinese patients.

Journal: Frontiers in immunology

Published: April 08, 2025

Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

Journal: Frontiers in immunology

Published: February 24, 2025

Showing 1-12 of 98

Last Updated: 09/26/2026